These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1117 related articles for article (PubMed ID: 9146930)

  • 1. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages.
    Gosset P; Tillie-Leblond I; Malaquin F; Durieu J; Wallaert B; Tonnel AB
    Clin Exp Allergy; 1997 Apr; 27(4):379-88. PubMed ID: 9146930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of TNFalpha on the human nasal mucosa in vivo.
    Widegren H; Korsgren M; Andersson M; Greiff L
    Respir Med; 2007 Sep; 101(9):1982-7. PubMed ID: 17532197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The time course of the bilateral release of cytokines and mediators after unilateral nasal allergen challenge.
    Wagenmann M; Schumacher L; Bachert C
    Allergy; 2005 Sep; 60(9):1132-8. PubMed ID: 16076297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal fluticasone propionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen-induced rhinitis.
    Weido AJ; Reece LM; Alam R; Cook CK; Sim TC
    Ann Allergy Asthma Immunol; 1996 Nov; 77(5):407-15. PubMed ID: 8933780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Myeloperoxidase (MPO) as a marker of neutrophil influx into nasal mucosa after recombinant IL-8 challenge].
    Kupczyk M; Bocheńska-Marciniak M; Górski P; Kuna P
    Pneumonol Alergol Pol; 2002; 70(11-12):544-9. PubMed ID: 12884563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mediator release of neuropeptides after nasal provocation in perennial allergic rhinitis patients.
    Gawlik R; DuBuske L
    Rhinology; 2010 Jun; 48(2):206-10. PubMed ID: 20502762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challenge.
    Erin EM; Zacharasiewicz AS; Nicholson GC; Tan AJ; Higgins LA; Williams TJ; Murdoch RD; Durham SR; Barnes PJ; Hansel TT
    Clin Exp Allergy; 2005 Dec; 35(12):1608-14. PubMed ID: 16393327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-6 and interleukin-1 alpha production is associated with antigen-induced late nasal response.
    Gosset P; Malaquin F; Delneste Y; Wallaert B; Capron A; Joseph M; Tonnel AB
    J Allergy Clin Immunol; 1993 Dec; 92(6):878-90. PubMed ID: 8258622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 17 and RANTES levels in induced sputum of patients with allergic rhinitis after a single nasal allergen challenge.
    Semik-Orzech A; Barczyk A; Wiaderkiewicz R; Pierzchala W
    Ann Allergy Asthma Immunol; 2009 Nov; 103(5):418-24. PubMed ID: 19927541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bet v 1-specific IgA increases during the pollen season but not after a single allergen challenge in children with birch pollen-induced intermittent allergic rhinitis.
    Keen C; Johansson S; Reinholdt J; Benson M; Wennergren G
    Pediatr Allergy Immunol; 2005 May; 16(3):209-16. PubMed ID: 15853949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophils, specific hyperreactivity and occurrence of late phase reaction in allergic rhinitis.
    Milanese M; Ricca V; Canonica GW; Ciprandi G
    Eur Ann Allergy Clin Immunol; 2005 Jan; 37(1):7-10. PubMed ID: 15745370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor in allergen-induced nasal inflammation.
    Choi GS; Park HJ; Hur GY; Choi SJ; Shin SY; Ye YM; Park HS
    Clin Exp Allergy; 2009 May; 39(5):655-61. PubMed ID: 19236408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of topical levocabastine on nasal response to allergen challenge and nasal hyperreactivity in perennial rhinitis.
    de Graaf-in 't Veld T; Garrelds IM; van Toorenenbergen AW; Mulder PG; Gerth van Wijk R; Boegheim JP
    Ann Allergy Asthma Immunol; 1995 Sep; 75(3):261-6. PubMed ID: 7552929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Humoral mucosal immunity in allergic rhinitis].
    Kramer MF; Jordan TR; Pfrogner E; Rasp G
    Laryngorhinootologie; 2005 Jul; 84(7):503-10. PubMed ID: 16010632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diminished response to grass pollen allergen challenge in subjects with concurrent house dust mite allergy.
    Reinartz SM; van Ree R; Versteeg SA; Zuidmeer L; van Drunen CM; Fokkens WJ
    Rhinology; 2009 Jun; 47(2):192-8. PubMed ID: 19593978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasal challenge with allergen leads to maxillary sinus inflammation.
    Baroody FM; Mucha SM; Detineo M; Naclerio RM
    J Allergy Clin Immunol; 2008 May; 121(5):1126-1132.e7. PubMed ID: 18367240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trial design, nasal allergen challenge models, and considerations of relevance to pediatrics, nasal polyposis, and different classes of medication.
    Akerlund A; Andersson M; Leflein J; Lildholdt T; Mygind N
    J Allergy Clin Immunol; 2005 Mar; 115(3 Suppl 1):S460-82. PubMed ID: 15746883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-13 is essential to the late-phase response in allergic rhinitis.
    Miyahara S; Miyahara N; Matsubara S; Takeda K; Koya T; Gelfand EW
    J Allergy Clin Immunol; 2006 Nov; 118(5):1110-6. PubMed ID: 17088137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of IL-6, IL-8, and GM-CSF release in nasal secretions of allergic patients after nasal challenge.
    Ohkubo K; Ikeda M; Pawankar R; Gotoh M; Yagi T; Okuda M
    Rhinology; 1998 Dec; 36(4):156-61. PubMed ID: 9923057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of sphingosine 1-phosphate receptor expression in eosinophils of patients with allergic rhinitis, and effect of topical nasal steroid treatment on this receptor expression.
    Mackle T; Gendy SS; Walsh M; McConn-Walsh R; Costello RW; Walsh MT
    J Laryngol Otol; 2008 Dec; 122(12):1309-17. PubMed ID: 18808729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.